Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma.

Ediriwickrema, Lilangi S; Liu, Catherine Y; Kikkawa, Don O; Korn, Bobby S

Ediriwickrema, Lilangi S; Liu, Catherine Y; Kikkawa, Don O; Korn, Bobby S.

Afiliação

Ediriwickrema LS; Division of Oculofacial Plastic and Reconstructive Surgery, UC San Diego Viterbi Family Department of Ophthalmology, Shiley Eye Institute.
Liu CY; Division of Oculofacial Plastic and Reconstructive Surgery, UC San Diego Viterbi Family Department of Ophthalmology, Shiley Eye Institute.
Kikkawa DO; Division of Oculofacial Plastic and Reconstructive Surgery, UC San Diego Viterbi Family Department of Ophthalmology, Shiley Eye Institute.
Korn BS; Division of Plastic and Reconstructive Surgery, UC San Diego Department of Surgery, La Jolla, California, U.S.A.

Ophthalmic Plast Reconstr Surg ; 35(5): e121-e122, 2019.

Article em En | MEDLINE | ID: mdl-31373986

ABSTRACT

ABSTRACT

The authors describe a clinical case whereby a patient with metastatic cutaneous melanoma developed eyelash poliosis after undergoing treatment with combination immunotherapy with ipilimumab and nivolumab.

Assuntos

Antineoplásicos Imunológicos/efeitos adversos; Imunoterapia/efeitos adversos; Ipilimumab/efeitos adversos; Nivolumabe/efeitos adversos; Transtornos da Pigmentação/induzido quimicamente; Pestanas; Feminino; Humanos; Melanoma/tratamento farmacológico; Pessoa de Meia-Idade; Neoplasias Cutâneas/tratamento farmacológico; Melanoma Maligno Cutâneo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Pigmentação / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Imunoterapia Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google